Your browser doesn't support javascript.
loading
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial.
Jering, Karola S; Claggett, Brian L; Pfeffer, Marc A; Granger, Christopher B; Køber, Lars; Lewis, Eldrin F; Maggioni, Aldo P; Mann, Douglas L; McMurray, John J V; Prescott, Margaret F; Rouleau, Jean L; Solomon, Scott D; Steg, Phillippe Gabriel; von Lewinski, Dirk; Braunwald, Eugene.
Affiliation
  • Jering KS; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School Boston, MA (K.S.J., B.L.C., M.A.P., S.D.S., E.B.).
  • Claggett BL; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School Boston, MA (K.S.J., B.L.C., M.A.P., S.D.S., E.B.).
  • Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School Boston, MA (K.S.J., B.L.C., M.A.P., S.D.S., E.B.).
  • Granger CB; Division of Cardiology, Duke University School of Medicine, Durham, NC (C.B.G.).
  • Køber L; Heart Centre, Ringshospitalet Copenhagen University Hospital, Denmark (L.K.).
  • Lewis EF; Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, CA (E.F.L.).
  • Maggioni AP; ANMCO Research Center, Heart Care Foundation, Florence, Italy (A.P.M.).
  • Mann DL; Department of Medicine, Washington University, St Louis, MO (D.L.M.).
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Scotland (J.J.V.M.).
  • Prescott MF; Novartis Pharmaceutical Corporation, East Hanover, NJ (M.F.P.).
  • Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, QB, Canada (J.L.R.).
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School Boston, MA (K.S.J., B.L.C., M.A.P., S.D.S., E.B.).
  • Steg PG; Université Paris-Cité, Institut Universitaire de France, AP-HP (Assistance Publique-Hôpitaux de Paris), FACT (French Alliance for Cardiovascular Trials) and INSERM U-1148, Paris, France (P.G.S.).
  • von Lewinski D; Department of Cardiology, Medical University of Graz, Austria (D.v.L.).
  • Braunwald E; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School Boston, MA (K.S.J., B.L.C., M.A.P., S.D.S., E.B.).
Circ Heart Fail ; 16(5): e010259, 2023 05.
Article in En | MEDLINE | ID: mdl-37125529

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Circ Heart Fail Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Circ Heart Fail Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Country of publication: